Salicylism from topical salicylates: Review of the literature

Clinical Toxicology

Volumn 34, Issue 4, 1996, Pages 431-436

  Brubacher, Jeffrey R ^a   Hoffman, Robert S ^a,b  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CHARCOAL; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE;

AGED; CASE REPORT; CONFERENCE PAPER; CONFUSION; DRUG BLOOD LEVEL; ERYTHRODERMA; FEMALE; HUMAN; INTENSIVE CARE; PARANOIA; REHYDRATION; TOPICAL DRUG ADMINISTRATION;

ACIDOSIS; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; CONFUSION; DERMATITIS, EXFOLIATIVE; DRUG MONITORING; FEMALE; HUMANS; KERATOLYTIC AGENTS; PARANOID DISORDERS; RISK FACTORS; SALICYLIC ACID; SALICYLIC ACIDS; SLEEP STAGES;

EID: 0029680623     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563659609013814     Document Type: Conference Paper

References (31)

1. Maurer TA, Winter ME, Koo J, Berger TG. Refractory hypoglycemia: a complication of topical salicylate therapy. Arch Dermatol 1994;130:1455-1457. (Pubitemid 24345799)
2. Gip L, Hamfelt A. Percutaneous absorption of betamethasone-17, 21 dipropionate and salicylic acid during the treatment of psoriasis and eczema. J Jnt Med Res 1976;4:106-110.
3. Davies MG, Briffa DV, Greaves MW. Systemic toxicity from topically applied salicylic acid. BMJ 1979;1:661. (Pubitemid 9145052)
4. Roberts MS, Favretto WA, Meyer A, Reckmann M, Wongseelashote T. Topical bioavailability of methyl salicylate. Aust NZJ Med 1982;12:303-305. (Pubitemid 12023500)
5. Heng MC. Local necrosis and interstitial nephritis due to topical methyl salicylate and menthol. Cutis 1987;39:442-444. (Pubitemid 17099302)
6. Rose FA, Wiemer DR. Platelet coagulopathy secondary to topical salicylate use. Ann Plast Surg 1983;11:340-343.
7. Oziomek RS, Perrin DH, Herold DA, Denegar CR. Effect of phonophoresis on serum salicylate levels. Med Sci Sports Exerc 1991;23:397-401.
8. Lotte C, Wester RC, Rougier A, Maibach HI. Racial differences in the in vivo percutaneous absorption of some organic compounds: a comparison between black, Caucasian and Asian subjects. Arch Dermatol Res 1993;284:456-459. (Pubitemid 23085784)
9. Guy RH, Hadgraft J. Structure-activity correlations in percutaneous absorption. In: Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery, 2nd ed. Bronaugh RL, Maibach HI, eds. New York: Marcel Dekker, 1989:95-109.
10. Rougier A, Dupuis D, Lotte C, Maibach HI. Stripping method for measuring percutaneous absorption in vivo. In: Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery, 2nd ed. Bronaugh RL, Maibach HI, eds. New York: Marcel Dekker, 1989:415-434.
11. Wester RC, Maibach HI. Dermal decontamination and percutaneous absorption. In: Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery, 2nd ed. Bronaugh RL, Maibach HI, eds. New York: Marcel Dekker, 1989, 335-342.
12. Bailey RB, Jones SR. Chronic salicylate intoxication. A common cause of morbidity in the elderly. J Am Geriatr Soc 1989;37:556-561. (Pubitemid 19135929)
13. Anderson RJ, Potts DE, Gabow PA, Rumack BH, Schrier RW. Unrecognized adult salicylate intoxication. Ann Intern Med 1976;85:745-748.
14. Roskos KV, Maibach HI, Guy RH. The effect of aging on percutaneous absorption in man. J Pharmaco Mnet Biopharm 1989;17:617-630. (Pubitemid 20162866)
15. Danon A, Ben-Shimon S, Ben-Zvi Z. Effect of exercise and heat exposure on percutaneous absorption of methyl salicylate. Eur J Clin Pharmacol 1986;31:49-52. (Pubitemid 16017451)
16. Sanchez MR. Dermatologic principles. In: Goldfrank's Toxicologic Emergencies, 5th ed. Goldfrank LR, Flomenbaum NE, Lewin NA, et al. , eds. , Norwalk Connecticut: Appleton and Lange, 1994:319-344.
17. Von Weiss JF, Lever WF. Percutaneous salicylic acid intoxication in psoriasis. Arch Dermatol 1964;190:614-619.
18. Raschke R, Arnold-Capell PA, Richeson R, Curry SC. Refractory hypoglycemia secondary to topical salicylate intoxication. Arch Intern Med 1991; 151: 591-593.
19. Taylor JR, Halprin KM. Percutaneous absorption of salicylic acid. Arch Dermatol 1975;111:740-743.
20. Gross H, Greenberg LA. Salicylates: Critical Bibliographic Review. New Haven, Connecticut: Hillhouse Press, 1948.
21. Summons WH. Clinical notes: Case 1. Poisoning from skin absorption of salicylic acid. Intercolon Med J 1904:518-519.
22. Young CJ. Salicylate intoxication from cutaneous absorption of salicylic acid. South Med J 1952;145: 1075-1077.
23. Cawley EP, Peterson NT, Wheeler CE. Salicylic acid poisoning in dermatological therapy. JAMA 1953; 151:372-374.
24. Lindsey CP. Two cases of fatal salicylate poisoning after topical application of an antifungal solution. Med JAus 1968;1:353-354.
25. Anderson JA, Ead RD. Percutaneous salicylate poisoning. Oin Exp Dermatol 1979;4:349-351. (Pubitemid 10221144)
26. Smith WO, Lyons D. Metabolic acidosis associated with percutaneous absorption of salicylic acid. J Okla State Med Assoc 1980;73:7-8.
27. Dwyer CM, McCloskey RH, Keri RE. Poisoning from topical salicylic acid. Postgrad Med J 1994;70: 146.
28. Ward PS, Jones RD. Successful treatment of a harlequin fetus. Arch Dis Child 1989;64:1309-1311. (Pubitemid 19220780)
29. Shupp DL, Schroeter AL. An unusual case of salicylate toxicity. J Am Acad Dermatol 1986;15: 300-301. (Pubitemid 16070360)
30. Aspinall JB, Goel KM. Salicylate poisoning in dermatological therapy. BMJ 1978;2:1373.
31. Galea P, Goel KM. Salicylate poisoning in dermatological treatment. Arch Dis Child 1990;65: 335. (Pubitemid 20108919)